diabetic nephropathy

Open Access
Preserving Kidney Function Instead of Replacing It
Alan S. Kliger, Frank C. Brosius and on behalf of the Diabetic Kidney Disease Task Force of the American Society of Nephrology*

CJASN January 2020, 15 (1) 129-131; DOI: https://doi.org/10.2215/CJN.07820719

Add to Selected Citations
Open Access
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin and Eugene P. Rhee

CJASN December 2019, CJN.07420619; DOI: https://doi.org/10.2215/CJN.07420619

Add to Selected Citations
Open Access
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
Katherine R. Tuttle, David Z. Cherney and on behalf of the Diabetic Kidney Disease Task Force of the American Society of Nephrology

CJASN November 2019, CJN.07730719; DOI: https://doi.org/10.2215/CJN.07730719

Add to Selected Citations
You have accessRestricted Access
Hypoglycemia in People with Type 2 Diabetes and CKD
Iram Ahmad, Leila R. Zelnick, Zona Batacchi, Nicole Robinson, Ashveena Dighe, Jo-Anne E. Manski-Nankervis, John Furler, David N. O’Neal, Randie Little, Dace Trence, Irl B. Hirsch, Nisha Bansal and Ian H. de Boer

CJASN June 2019, 14 (6) 844-853; DOI: https://doi.org/10.2215/CJN.11650918

Add to Selected Citations
You have accessRestricted Access
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes
Amy K. Mottl, John B. Buse, Faramarz Ismail-Beigi, Ronald J. Sigal, Carolyn F. Pedley, Vasilios Papademetriou, Debra L. Simmons, Lois Katz, Josyf C. Mychaleckyj and Timothy E. Craven

CJASN November 2018, 13 (11) 1693-1702; DOI: https://doi.org/10.2215/CJN.06200518

Add to Selected Citations
You have accessRestricted Access
COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu

CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

Add to Selected Citations
Open Access
Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease
Hiddo J.L. Heerspink and Vlado Perkovic

CJASN June 2018, 13 (6) 946-948; DOI: https://doi.org/10.2215/CJN.01290118

Add to Selected Citations
Open Access
Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report
Bryan M. Tucker and Barry I. Freedman

CJASN March 2018, 13 (3) 477-479; DOI: https://doi.org/10.2215/CJN.08310817

Add to Selected Citations
Open Access
Effects of Diabetes Medications Targeting the Incretin System on the Kidney
Richard J. MacIsaac and Merlin C. Thomas

CJASN February 2018, 13 (2) 321-323; DOI: https://doi.org/10.2215/CJN.10380917

Add to Selected Citations
You have accessRestricted Access
Diabetes and CKD in the United States Population, 2009–2014
Leila R. Zelnick, Noel S. Weiss, Bryan R. Kestenbaum, Cassianne Robinson-Cohen, Patrick J. Heagerty, Katherine Tuttle, Yoshio N. Hall, Irl B. Hirsch and Ian H. de Boer

CJASN December 2017, 12 (12) 1984-1990; DOI: https://doi.org/10.2215/CJN.03700417

Add to Selected Citations

Main menu

User menu

Search

diabetic nephropathy

Pages

About

Author Information

More information